Professional Documents
Culture Documents
Introduction To Sitlab MedTech v1.2
Introduction To Sitlab MedTech v1.2
Introduction To Sitlab MedTech v1.2
Leon Mutambala
CEO
Sitlab MedTech
Jasim Abassi
Lead Developer
Sitlab MedTech
Sitlab Technology’s MedTech platform provides secondary analysis of whole genome Sequencing / DNA using data-
driven computational (AI/ML) pipelines based on hardware acceleration and utilising scalable Cloud storage and
computation fabric.
High power computing and advanced data science technologies help propel genomics forward and deliver on its clinical
promise, enhancing customer capabilities to analyse and interpret the data produced by the sequencing systems.
Using Artificial Intelligence reduces clinical trial cycle times while improving the costs of productivity and accelerates
outcomes of clinical development.
• Sitlab is proud to be part of the Uppsala Innovation Centre Business Start-up Programme which helped our team to further develop our
innovative business idea and verify that it has the potential to succeed.
• During the last three months we were able to make good connections and collaborate with other participants, mentors and investors, providing
us valuable feedback on our innovation.
• This has helped us to further develop our system for secondary analysis of whole genome Sequencing / DNA using data-driven computational
(AI/ML) pipelines based on hardware acceleration and utilising scalable Cloud computation fabric.
• This enhances customer capabilities to analyse and interpret the data produced by the sequencing systems.
• We believe we can merge high power computing and advanced data science technologies to help propel genomics forward and deliver on its
clinical promise.
• We believe that artificial intelligence can reduce clinical trial cycle times while improving the costs of productivity and outcomes of clinical
development.
• Predictive AI models and analytics tools can accelerate the understanding of diseases, identify suitable patients and key investigators to inform
site selection, and support novel clinical study designs.
• AI algorithms, combined with an effective digital infrastructure, could enable the continuous stream of clinical trial data to be cleaned,
aggregated, coded, stored and managed.
• Researchers
• Uppsala University
• SLU University
• Karolinska Institutet
• Lund Universitet
• Scilifelab
• Uppsala Business Park
• Umea University
• MedTech groups on social media such as LinkedIn, twitter, Facebook, Instagram, research gate
etc
• MedTech exhibitions and conferences
• Direct contacts at Research Centres and Universities
• Innovation Workshops
On-premise
AWS Cloud/Outpost
AWS Direct Connect
Cloud Engine Command Line
Master
Genomics Workbench
Job Instances
VPN Qumulo
File System
Datacenter
Qumulo
Replication
AWS S3
Long term
Genomics Qumulo archive
Servers (GxS) File System
Data Analytics in the Cloud (AWS)
Build and deploy custom workflows on the fly Reusable workflows and reference data
Push local data to the cloud Store data, results, report on Amazon S3
Pull result and report down Dynamically scales on demand
Web portal for monitoring cloud process Secure and reliable platform
Datacenter VPC
Amazon
Computer Farm Database and Machine
Repository Spot Fleet GPU
Image
AWS Direct
Connect
FPGA
Data ingest
Qumulo Qumulo
replication Qumulo Shift to S3 AWS S3
Qumulo Long term archive
File System File System
Sitlab is planning to create a global network for its MedTech platform across the major
AWS regions North America (Northern Virginia), South America (Sao Paulo), Europe
(Dublin) / Middle East (Bahrein) / Africa (cape Town) and Asia Pacific (Mumbai, Hong
Kong, Tokyo and Sydney). Each AWS region is fully isolated from each other.
The main benefit to set up a global network is to overcome regulatory constraints in each
region that interpret the use of AI differently.
Protection and Ownership of Data: Some countries to not permit the processing of
sensitive data outside the region.
Ireland
Copyrights, Patents and Trade Secrets of AI Algorithms: Jurisdictions treat differently to
legally protect ownership rights related to AI algorithms. Tokyo
Regulations/government interventions: Legislation relating to consumer protection, Northern Virginia
privacy and product safety is applicable to AI systems even if they are not expressively Bahrain Hong Kong
mentioned in the legislation and this may lead to inappropriate outcomes as the Mumbai
legislation is not necessarily aimed to be applied to new technologies as AI.
Civil Liability: AI systems do not have legal capacity and cannot be held liable for
damages. This needs to be addressed by each jurisdiction. Sao Paulo
Discrimination and Bias: AI systems will learn from data input it gets. If the data is biased Cape Town Sydney
or discriminatory in any way, so will be the AI system. Discrimination laws are differently
applied and, in most cases, inadequate for the future.
Sitlab MedTech
leonm@sitlab.se
jasim@sitlab.se